Sustainability Report 2025
V-OVS® next: A new standard for Luer Lock syringe closure systems
News
Stay up to date on what's happening at Vetter.
CDMO Insights
Sharpen your edge with our expertise.
Job Vacancies
As oligonucleotide-based therapies continue to advance from research into clinical and commercial applications, robust analytical methods are becoming…
09/15/2026
Across the pharmaceutical industry, digital technologies are transforming manufacturing. Much of this work has been behind the scenes, involving…
09/14/2026
For sponsors developing innovative injectables, choosing a contract development and manufacturing organization (CDMO) for aseptic fill-finish can be…
07/21/2026
Find out how this purpose-built system brings a new level of efficiency and safety to critical logistics processes.
06/15/2026
Published evidence now confirms the efficacy of an approach Vetter has leveraged for a decade to minimize intervention risk.
04/09/2026
A device assembly & packaging expert shares how Vetter is navigating global demand for self-administered injectable therapies.
02/24/2026
At Vetter, the transition towards renewable energy is progressing rapidly, combining advanced technologies and robust regional partnerships. Through…
02/16/2026
Discover how we unlocked greater productivity at our production sites by investing in pure media supply.
01/16/2026
Learn how our CPV program uses statistical trend analyses to proactively detect anomalies and support process performance.
11/28/2025
Vetter’s senior legal counsel Jana Falkenberg shares how we’ve made corporate compliance the foundation of our operational strategy.
10/21/2025
Since November 2023, Vetter has been a proud member of the Science Based Targets initiative (SBTi), a global community committed to achieving climate…
09/09/2025
Major shifts are quickly reshaping our market’s global resource flows. Here’s what a Vetter expert sees ahead for CDMOs.
08/15/2025
Quick access to the latest press releases and company information.
To the press portal
